The Use of Extracorporeal Membrane Oxygenation in Neonates With Congenital Renal Failure

jpedsurg.org

Extracorporeal membrane oxygenation (ECMO) provides support for patients whose heart and lungs cannot oxygenate and circulate blood effectively. ECMO utilization in patients with congenital renal failure (CRF) is variable as are survival outcomes, ranging from 42 to 80 %. We aim to understand ECMO utilization and outcomes in patients with CRF at a free-standing, quaternary care children's hospital with a fetal care center.

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Aug 2025 · 1 min read

In brief

This study examines ECMO utilization and survival outcomes in neonates with congenital renal failure at a quaternary pediatric center with fetal care capabilities. Given the variable survival rates (42-80%) reported in this population, the research aims to clarify best practices for cardiopulmonary support in neonates facing both renal and respiratory challenges.

ECMO provides cardiopulmonary support when native heart and lungs cannot adequately oxygenate blood.
Survival rates for neonates with congenital renal failure on ECMO vary widely (42-80%).
ECMO utilization in CRF patients remains inconsistent across institutions.
Quaternary pediatric centers with fetal programs may offer insights into optimizing ECMO use in CRF.

Written by the GCMD Library team from the article.

Read it at the source ↗